GENPREX (GNPX)
(Delayed Data from NSDQ)
$0.21 USD
-0.01 (-3.43%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.21 0.00 (-1.78%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, GENPREX has a market cap of $7.34M, which represents its share price of $0.22 multiplied by its outstanding shares number of 33.15M. As a small-cap company, GNPX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GNPX 0.21 -0.01(-3.43%)
Will GNPX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GNPX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for GNPX
Genprex Issues Stockholder Letter and Provides 2025 Corporate Update | GNPX Stock News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Genprex (GNPX) Unveils Promising Preclinical Results for Diabetes Therapy | GNPX Stock News
Genprex Announces Positive Preclinical Results for GPX-002
Genprex Collaborators Present Positive Preclinical Research on Diabetes Gene Therapy at the ...